AU2017221772B2 - Use of excess carbodiimide for peptide synthesis at elevated temperatures - Google Patents

Abstract

USE OF EXCESS CARBODIIMIDE FOR PEPTIDE SYNTHESIS AT ELEVATED TEMPERATURES Abstract An improved method of coupling amino acids into peptides or peptidomimetics is disclosed in which the activation and coupling are carried out in the same vessel, in the presence of a carbodiimide in an amount greater than 1 equivalent as compared to the amino acid, in the presence of an activator additive, and at a temperature greater than

Description

USE OF EXCESS CARBODIIMIDE FOR PEPTIDE SYNTHESIS AT ELEVATED TEMPERATURES

Background [0001] The present disclosure relates to peptide synthesis and in particular relates to solid phase peptide synthesis (SPPS).

[0002] The reference to prior art in this specification is not and should not be taken as an acknowledgment or any form of suggestion that the referenced prior art forms part of the common general knowledge in Australia or in any other country.

[0003] A number of acronyms are used throughout the specification and claims. They are generally familiar to the skilled person. As used herein they have the following meanings· [0004] EtOH: ethanol [0005] HBTU· 2-(lH-benzotriazol·l-yl)-l,l,3,3-tetramethyluronium hexafluorophosphate.

[0006] HATU· l-[Bis(dimethylamino)methylene]-lH-l,2,3-triazolo[4,5-b]pyridinium 3-oxid hexafluorophosphate.

[0007] HCTlh l-[Bis(dimethylamino)methylen]-5-chlorobenzotriazolium 3-oxide hexafluorophosphate.

[0008] PyBOP: benzotriazol-l-yl-oxytripyrrolidinophosphonium hexafluorophosphate.

[0009] PyAOP· 7-Azabenzotriazol-l-yloxy)tripyrrolidinophosphonium hexafluorophosphate.

[0010] DIEA: Diisopropylethylamine.

[0011] NMM: N-Methylmorpholine.

[0012] Cys(Trt): Cysteine(trityl).

[0013] DMAP: 4-Dimethylaminopyridine.

[0014] NMP: N-Methyl-2-pyrrolidone.

[0015] TIS· triisopropylsilane.

[0016] DODL 3,6-Dioxa-l,8-octane-dithiol.

[0017] ΜΒΗΛ: (4-methylbenzhydrylamine).

[0018] Probably the most commonly used and studied activation method for peptide synthesis is based on the use of carbodiimides. Their use in peptide synthesis dates back to 1955 where Ν,Ν’-dicyclohexylcarbodiimide (DCC) was used to facilitate amide bond formation. A carbodiimide contains two slightly basic nitrogen atoms which will react with the carboxylic acid of an amino acid derivative to form a highly reactive O-acylisourea compound as shown in Figure 1. The formed O-acylisourea can then immediately react with an amine to form a peptide bond or be converted into other reactive species.

[0019] The high reactivity of O-acylisourea also promotes several other undesirable pathways that may or may not lead to peptide bond formation as also shown in Figure 1. Conversion to the unreactive N-acylurea prevents coupling while epimerization of an activated chiral amino acid can occur through oxazolone formation. A highly reactive symmetrical anhydride can be formed by using excess amino acid compared to the carbodiimide. However, this approach undesirably consumes an additional amino acid equivalent.

[0020] A significant improvement for carbodiimide activation methods occurred with the incorporation of 1-hydroxybenzotriazole (HOBt) as an additive during carbodiimide activation. HOBt quickly converts the O-acylisourea into an OBt ester that is highly reactive and avoids undesirable N-acylisourea and oxazolone formation. It was later demonstrated that l-Hydroxy-7-azabenzotriazole (HOAt) is an advantageous replacement for HOBt due to a neighboring group effect of the nitrogen at the 7-position [161]. Many other additives can be used in place of HOBt and HOAt such as 6-chloro-l-hydroxybenzotriazole (6-Cl'HOBt), ethyl 2-cyano-2-(hydroxyimino)acetate (Oxyma, OxymaPure, ECHA), and l-hydroxy-2,5-pyrrolidinedione (NHS) to list several common examples.

[0021] Typically, 1 equivalent of additive is added compared to the amino acid and carbodiimide. A recent study suggested, however, that reduction of additives to less than 1 equivalent may be useful. (S. Nozaki, "Delay of coupling caused by excess additives," J. Pept. Sci., vol. 12, pp. 147Ί53, 2006.). The authors found that the acylation reaction could be hindered by salt formation between the amine and additive. The authors also found, however, that reducing additives to less than 1 equivalent slowed down the activation rate and slightly increased epimerization in segment couplings.

The Remainder of this Page is Intentionally Left Blank

[0022] Figure 1 Carbodiimide Based Activation.

[0023] Ν,Ν’-Diisopropylcarbodiimide (DIC) has largely replaced DCC as the preferred carbodiimide for peptide activation. DCC undesirably produces a urea soluble only in TFA which makes its use difficult for Fmoc chemistry. Additionally, DCC is a waxy solid that can be difficult to work with and has been reported to cause allergic reactions. Alternatively, DIC is advantageous due to the improved solubility of its generated urea in organic solvents, lower incidence of reported allergic reactions, and similar low cost as DCC. One of the most popular coupling methods still in use today is based on DIC/HOBt due to its low cost and side reactions while routinely providing effective couplings.

[0024] Recent analysis of benzotriazole based additives such as HOBt, HOAt, and 6-C1-HOBt have led to their reclassification as class 1 explosives. This undesirable feature of benzotriazole additives has increased interest in developing suitable alternatives for the benzotriazole additives. One such alternative is Oxyma (ethyl 2-cyano-2-(hydroxyimino)acetate), first reported in 1973. (See, M. Itoh, "Peptides. IV. Racemization

Suppression by the Use of Ethyl-2-Hydroximino-2-cyanoacetate and Its Amide," Bull. Chem. Soc. Jpn., vol. 46, pp. 2219-2221, 1973.). More recently, the explosive properties of Oxyma were tested by differential scanning calorimetry (DSC) as well as accelerating rate calorimetry (ARC) with favorable results as compared to HOBt. (R. Subiros-Funosas, "Oxyma^ An Efficient Additive for Peptide Synthesis to Replace the Benzotriazole-Based HOBt and HOAt with a Lower Risk of Explosion," Chemistry, vol. 15, pp. 9394-9403, 2009.).

[0025] Nevertheless, the use of carbodiimide based activation methods under room temperature synthesis conditions can lead to high levels of deletions due to both a relatively slow activation process and more acidic coupling environment. This has led to the more recent development of onium salt based activation methods which are more rapid. Onium salt based activation requires, however, the use of a base which first deprotonates the carboxylic acid thereby generating a carboxylate anion which reacts with the onium salt activator. Improved coupling has been demonstrated with many onium salts (HBTU, HATU, PyBOP, PyAOP, HCTU, among others) compared to carbodiimide based activation at room temperature conditions.

The Remainder of this Page is Intentionally Left Blank [0026] Figure 2 Onium Salt Based Activation

[0027] Starting in the early 2000’s the use of heating during SPPS has been extensively applied as a method to improve amino acid coupling. Heating in peptide synthesis can be achieved by microwave irradiation or other known conventional heating methods, and has been used with both standard carbodiimide and onium salt coupling processes. Nevertheless, an elevated temperature during the coupling step presents several challenges for peptide synthesis. Using onium salt based activation methods, epimerization of cysteine derivatives is substantially increased at elevated temperatures based upon the presence of the base (typically DIEA, NMM). Additionally, increased δ-lactam formation of arginine during activation has been observed and leads to major arginine deletions in certain sequences.

[0028] Recently, Collins et al. showed that very rapid and efficient couplings could be performed by in-situ carbodiimide based couplings at 90°C without the presence of any base. (J. Collins, K. Porter, S. Singh and G. Vanier, "High-Efficiency Solid Phase Peptide Synthesis (HE-SPPS)," Org. Lett., vol. 16, pp. 940-943, 2014.) This demonstrates that microwave irradiation is capable of accelerating both the slow activation process and subsequent acylation step! e.g., in 2 minutes at 90°C. The absence of base during the Collins et al coupling process advantageously avoided the hindered activation described by Carpino et al. and Beyermann et al, and provided a safer coupling environment from epimerization. In fact Collins et al showed that Fmoc-Cys(Trt)OH could be coupled at 90°C without an increase in epimerization compared to room temperature methods. (L. Carpino, "The Diisopropylcarbodiimide/1-Hydroxy-7-azabenzotriazole System: Segment Coupling and Stepwise Peptide Assembly," Tetrahedron, vol. 55, pp. 6813-6830, 1999; M. Beyermann, "Effect of tertiary amine on the carbodiimide-mediated peptide synthesis," Int. J. Peptide Protein Res., vol. 37, pp. 252-256, 1991.) [0029] Nevertheless, the more acidic environment at higher temperatures required to drive the less reactive carbodiimide activation (compared to onium salts) will lead to premature cleavage of peptides attached to hyper-acid sensitive linkers (ex. 2-chlorotrityl). This can results in total loss of peptide from the resin and significantly limits the temperature that can be applied with this class of linkers. The use of hyper-acid sensitive linkers is important in certain peptide syntheses because they allow for peptide fragment condensation which allows for larger peptide sequences to be constructed. Hyper-acid linkers are also important for avoiding side reactions such as diketopiperazine formation, avoiding DMAP during resin loading, and avoiding beta-elimination of c-terminal cysteine residues connected to acid linkers.

[0030] Therefore, a peptide chemist faces limitations when applying elevated temperature to the coupling step in peptide synthesis with either carbodiimide or onium salt based activation methods.

[0031] It has been suggested that excess carbodiimide is reactive with amino groups and is undesirable for peptide bond formation which has led to avoidance in the use of excess carbodiimides. However, in rare cases the use of excess carbodiimide has been explored. In one report, excess DIC/HOBt was used relative to the amino acid with undesirable capping of the amino group by excess carbodiimide reported through the observation of N-acylurea peptide formation. (B. J. Egner, G. J. Langley and M. Bradley, J. Org. Chem., vol. 60, no. 9, pp. 2652-2653, 1995.).

[0032] The use of excess carbodiimide has also been viewed as undesirable due to the difficult solvation properties of formed acylureas after coupling. This is a particular challenge with DCC whose urea is insoluble in many solvents thereby requiring the use of dichloromethane (DCM). This factor has largely led to its replacement with DIC whose urea is more soluble in DMF.

[0033] Very recently, an improved coupling method for SPPS was presented in US 14/969,004, which demonstrated an improvement in coupling over both standard carbodiimide and onium salt based methods at elevated temperatures. This method is a modified carbodiimide activation strategy which features the use of a base. It was found that a strong base added at less than 1-equivalent compared to the amino acid, carbodiimide, and activator additive could be present during the entire activation and coupling process while both enhancing the overall coupling reaction and avoiding potential side reactions. Only a slight increase in epimerization was observed through the use of a limited amount of base.

[0034] In some aspects may incorporate the advantages of elevated temperatures while avoiding these various disadvantages.

Definition [0035] In the present description and claims, the term “comprising” shall be understood to have a broad meaning similar to the term “including” and will be understood to imply the inclusion of a stated integer or step or group of integers or steps but not the exclusion of any other integer or step or group of integers or steps. This definition also applies to variations on the term “comprising” such as “comprise” and “comprises”.

Summary [0036] According to one aspect of the present disclosure there is provided a method of coupling amino acids into peptides or peptidomimetics, the improvement comprising: carrying out activation and coupling in the same vessel, incorporating a carbodiimide in an amount between 1.5 and 4 equivalents as compared to the amino acid, in the presence of an activator additive, and at a temperature greater than 30°C.

[0037] A method of coupling amino acids into peptides or peptidomimetics is also disclosed in which the activation and coupling are carried out in the same vessel, in the presence of a carbodiimide in an amount greater than 1 equivalent as compared to the amino acid, in the presence of an activator additive, and at a temperature greater than 30°C.

[0038] In some embodiments the carbodiimide is present in an amount greater than 1.5 equivalents as compared to the amino acid.

[0039] In some embodiments the method is limited to a total coupling time less than 10 minutes.

[0040] In some embodiments the carbodiimide is present in an amount greater than 1.5 equivalents as compared to the amino acid.

[0041] In some embodiments the method is limited to a total coupling time less than 10 minutes and carried out at a temperature greater than 30°C.

[0042] In some embodiments the method includes limiting the amount of carbodiimide present to between about 1.5 and 4 equivalents compared to the amino acid.

[0043] In some embodiments the method is limited to a total coupling time less than 10 minutes and carried out at a temperature greater than 70°C.

[0044] In some embodiments the method is limited to a total coupling time less than 15 minutes.

[0045] In some embodiments, the method is a solid phase peptide synthesis (SPPS) method.

[0046] In some embodiments at least one of the added acids is initially Fmocprotected.

[0047] According to another aspect of the disclosure there is provided a composition for coupling amino acids into peptides or peptidomimetics, the composition comprising: an amino acid, an organic solvent, a carbodiimide in an amount between 1.5 and 4 equivalents as compared to said amino acid, and an activator additive.

[0048] The composition may further comprise between 1 and 1.5 equivalents of said activator additive.

[0049] The amino acid may be an Fmocprotected amino acid.

[0050] The composition may further comprise the Oacylisourea intermediate of the amino acid and the carbodiimide.

[0051] The composition may further comprise a DIC or Oxyma activator.

[0052] The composition may further comprise an ester of Oacylisourea of the amino acid and the activator additive.

[0053] The composition may comprise at least on amino acid linked to a solid phase peptide resin.

[0054] The composition may further comprise a peptide chain linked to a solid phase peptide synthesis resin.

[0055] The foregoing and other objects and advantages of the disclosed methods and compositions and the manner in which the same are accomplished will become clearer based on the followed detailed description.

Detailed Description [0056] An improved carbodiimide coupling method at elevated temperatures is presented that avoids the use of a strong base while simultaneously increasing coupling efficiency. This method is based on the unexpected improvement in coupling from the use of increased amounts of carbodiimide (greater than 1 equivalent) relative to the amino acid. It was found that this combination uniquely improved coupling efficiency through more rapid formation of the o_acylisourea intermediate, avoidance of expected N-acylurea peptide formation and/or capping of the terminal amino group, and reduction in epimerization compared to the use of base with carbodiimide coupling. The efficiency of this method was verified by synthesizing three difficult peptide sequences under various conditions as shown in Tables 1-3.

[0057] The disclosure also applies to the synthesis of peptidomimetics; i.e., small proteinlike chains designed to mimic a peptide. Because the coupling reactions described herein are for the most part identical as between peptides and peptidomimetics, the disclosed methods and compositions will be described in terms of peptides. The skilled person will, of course, understand this completely.

[0058] In a similar manner, the skilled person will understand that the term “amino acid” is used herein in its broadest sense to refer to the organic compounds that contain both amine and carboxylic acid functional groups usually along with a side chain. The skilled person is well aware of and familiar with the 22 amino acids that are naturally incorporated into polypeptides and are referred to as proteinogenic or natural amino acids.

Again, because the basic coupling reactions are not limited to these particular molecules, the skilled personal will recognize that the advantages of some aspects of the disclosed methods and compositions also apply to non-proteinogenic amino acids (aka "non-natural amino acids") of which 40 have been added into proteins using established synthetic steps. The results described herein use the well-established single letter designations for the amino acids in the synthesized peptides.

[0059] The basics of solid phase peptide chemistry have been well-established starting with the pioneering work of Merrifield (R. B. Merrifield (1963) "Solid Phase Peptide Synthesis I, The Synthesis of a Tetrapeptide," J. Am. Chem. Soc. 85 (14), 2149-2154. The frequently used Fmoc (9-fluorenylmethyloxycarbonyl) protecting-group approach is well described in references that are easily available to the skilled person; e.g., Chan and White, "Fmoc solid phase peptide synthesis, a practical approach, Oxford University Press (2000).

[0060] The LIBERTY BLUE™ instrument referred to in the experiments is available from CEM Corporation of Matthews North Carolina. Relevant US patents dealing with the subject of solid phase peptide synthesis at elevated temperatures and using microwave irradiation include, but are not necessarily limited to, the following: 7393920; 7550560; 7563865; 7939628; 7902488; 7582728; 8153761; 8058393; 8426560; 8846862; 9211522. The contents of these are incorporated entirely herein by reference.

[0061] Table 1 Synthesis of Thymosin with Various Amounts of Carbodiimide

[0062] Experiment Conditions: [0063] Peptide Sequence (Thymosin) = SDAAVDTSSEITTKDLKEKKEWEEAEN-NH2 [0064] Synthesis Scale = O.lmmol [0065] Resin = Rink Amide MBHA Polystyrene Resin (0.38 mmol/g) [0066] Instrument = Liberty Blue Microwave Peptide Synthesizer (CEM Corp., Matthews, NC) [0067] Deprotection = 3 mL of a 10% (w/v) piperazine in EtOILNMP (L9)

[0068] Microwave Deprotection Method = 1 min at 90°C

[0069] Washing = Post-Deprotection (2 mL, 2 mL, 3 mL - DMF); Post-Coupling = None [0070] Coupling = 5-fold excess of AA/DIC/Oxyma in 4mL solution [0071] Cleavage = 5mL of TFA/TIS/H20/DODt (92.5:2.5:2.5:2.5) for 30 min at 38°C in an Accent MW cleavage system (CEM Corp., Matthews, NC) [0072] Analysis = Peptides were analyzed on a Waters UPLC ACQUITY Η-Class with 3100 Single Quad MS using acetonitrile/water with 0.1 % TFA as the solvent system on C18 Column (l.7mm, 2.1 x 100mm) [0073] Table 2 Synthesis of GRP with Various Amounts of Carbodiimide

[0074] Experiment Conditions: [0075] Peptide Sequence (GRP) = VPLPAGGGTVLTKMYPRGNHWA VGHLM-NH2 [0076] Synthesis Scale = O.lmmol [0077] Resin = Rink Amide MBHA Polystyrene Resin (0.35 mmol/g) [0078] Instrument = Liberty Blue Microwave Peptide Synthesizer (CEM Corp., Matthews, NC) [0079] Deprotection = 3 mL of a 10% (w/v) piperazine in EtOH:NMP (L9)

[0080] Microwave Deprotection Method - 1 min at 90°C

[0081] Washing = Post-Deprotection (2 mL, 2 mL, 3 mL - DMF); Post-Coupling = None [0082] Coupling = 5-fold excess of AA/DIC/Oxyma in 4mL solution [0083] Cleavage = 5mL of TFA/TIS/H20/DODt (92.5:2.5:2.5:2.5) for 30 min at 38°C in an Accent MW cleavage system (CEM Corp., Matthews, NC) [0084] Analysis = Peptides were analyzed on a Waters UPLC ACQUITY Η-Class with 3100 Single Quad MS using acetonitrile/water with 0.1 % TFA as the solvent system on C18 Column (l.7mm, 2.1 x 100mm).

[0085] Table 3 Synthesis of Ubiquitin with Various Amounts of Carbodiimide

[0086] Experiment Conditions^ [0087] Peptide Sequence (Ubiquitin) = MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDY NIQKESTLHLVLRLRGG-NH2 [0088] Synthesis Scale = O.lmmol [0089] Resin = Fmoc-PAL-PEG-PS resin (0.20 mmol/g) [0090] Instrument = Liberty Blue Microwave Peptide Synthesizer (CEM Corp., Matthews, NC) [0091] Deprotection = 4 mL of a 10% (w/v) piperazine in EtOhhNMP (L9) + 0.1 M HOBt

[0092] Microwave Deprotection Method = 1 min at 90°C

[0093] Washing = Post-Deprotection (4x4 mL DMF); Post-Coupling = None [0094] Coupling = 5-fold excess of AA/DIC/Oxyma in 4mL solution [0095] Cleavage = 5mL of TFA/TIS/H20/DODt (92.5^2.5^2.5-2.5) for 30 min at 38°C in an Accent MW cleavage system (CEM Corp., Matthews, NC) [0096] Analysis = Peptides were analyzed on a Waters UPLC ACQUITY Η-Class with 3100 Single Quad MS using acetonitrile/water with 0.1 % TFA as the solvent system on C18 Column (l.7mm, 2.1 x 100mm) [0097] As shown in Table 1, a significant increase in purity was observed by increasing the carbodiimide excess relative to the amino acid (75% vs. 63%). Similar improvements were observed from other peptides synthesized as shown in Tables 2 and 3. Together, these results show that not only was coupling efficiency increased, but also that potential capping from the carbodiimide was avoided. This is presumably from the increased kinetics of acylation relative the capping which thereby avoids this potential side reaction. Additionally, the increased temperature of the coupling reaction is also helpful for ensuring the urea formed from the carbodiimide is fully soluble and removed during subsequent draining and washing steps. Therefore, elevated temperatures provide protection against potential solubility issues from larger amounts of urea generated through the use of greater than 1 equivalent of carbodiimide.

[0098] The epimerization of each amino acid was then investigated through hydrolysis, subsequent derivatization, and analysis by gas chromatography (CAT GmbH). We observed extremely low levels of epimerization using the excess carbodiimide method. This is presumably because the coupling reaction is completed the fastest (short lifetime for activated species) and no external base is present. Therefore, this method offers advantages over any previous method described for coupling at elevated temperatures to date.

[0099] Table 4 Epimerization Analysis of the Synthesis of Thymosin with 2-Equivalents of Carbodiimide

[0100] The use of bases during the coupling process is not ideal as they can lead to undesirable side reactions. Collins et al [7] showed how cysteine epimerization was minimal at 90°C under a carbodiimide based coupling method without the presence of any base. Palasek et al [13] had shown how significant cysteine epimerization can occur under onium salt activation methods with the presence of DIEA and NMM present at 2 equivalents. It is also known that the Fmoc protecting group is slowly labile to DIEA. This can be increased at higher temperatures and leads to undesirable insertion sequences which can be difficult to separate.

[0101] Table 5 Comparison of Carbodiimide and Onium Salt Activation Strategies for Peptide Coupling at Elevated Temperature

[0102] Table 6 Comparison of Carbodiimide Activation Strategies for Peptide Coupling at Elevated Temperature [0103] In the specification there has been set forth a preferred embodiment of the invention, and although specific terms have been employed, they are used in a generic and descriptive sense only and not for purposes of limitation, the scope of the invention being defined in the claims.

Claims (17)

1. Claims

   1. In a method of coupling amino acids into peptides or peptidomimetics, the improvement comprising: carrying out activation and coupling in the same vessel; incorporating a carbodiimide in an amount between 1.5 and 4 equivalents as compared to the amino acid; in the presence of an activator additive; and at a temperature greater than 30°C.
2. 2. A solid phase peptide synthesis (SPPS) method according to Claim 1.
3. 3. A method according to Claim 1 or Claim 2, in which at least one of the added acids is initially Fmocprotected.
4. 4. A method according to any one of Claims 1 to 3, carried out a temperature greater than 70°C.
5. 5. A method according to any of Claims 1 to 4, limited to a total coupling time less than 10 minutes.
6. 6. A method according to any of Claims 1 to 4, limited to a total coupling time less than 15 minutes.
7. 7. A method according to any of Claims 1 to 6, wherein the activator additive is present in an amount between 1 and 1.5 equivalents compared to the amino acid.
8. 8. A method according to any of Claims 1 to 6, wherein: the activator additive is present in an amount between 1 and 1.5 equivalents compared to the amino acid; and the coupling step is limited to less than 10 minutes.
9. 9. A method according to any of Claims 1 to 4, wherein: the activator additive is present in an amount between 1 and 1.5 equivalents compared to the amino acid; and the coupling step is limited to less than 15 minutes.
10. 10. A composition for coupling amino acids into peptides or peptidomimetics, the composition comprising: an amino acid; an organic solvent; a carbodiimide in an amount between 1.5 and 4 equivalents as compared to said amino acid; and an activator additive.
11. 11. The composition of Claim 10, wherein said composition further comprises between 1 and 1.5 equivalents of said activator additive.
12. 12. The composition of any one of Claims 10 to 11, wherein said amino acid is an Fmoc-protected amino acid.
13. 13. The composition of any one of Claims 10 to 12, further comprising the O acylisourea intermediate of said amino acid and said carbodiimide.
14. 14. The composition of Claim 13, further comprising a DIC or Oxyma activator.
15. 15. The composition of Claim 14, further comprising an ester of said Oacylisourea of said amino acid and said activator additive.
16. 16. The composition of any one of Claims 10 to 15, comprising at least one amino acid linked to a solid phase resin.
17. 17. The composition of any one of Claims 10 to 16, further comprising a peptide chain linked to a solid phase peptide synthesis resin.